Medtronic (MDT) Expands Partnership with Merit Medical for ViaVerte System

What: Medtronic has expanded its partnership with Merit Medical for the ViaVirta System, a minimally invasive treatment for obesity.
Why: The partnership aims to increase access to the ViaVirta System, which uses radiofrequency ablation to treat obesity.
Signal: The ViaVirta System has shown promising results in clinical trials, with a **70%** reduction in excess weight at six months.
Target: Medtronic and Merit Medical plan to launch the ViaVirta System in **15** new markets globally by the end of **2026**.
Risk: The ViaVirta System carries potential risks, including complications from radiofrequency ablation, such as burns or nerve damage.